100 employees
Chase Pharmaceuticals is engaged in the clinical development of medically improved treatments for central nervous system (CNS) diseases.
2016
$21M
from 2 investors over 2 rounds
Chase Pharmaceuticals raised $21M on May 12, 2014
Investors: Andera Partners and New Rhein Healthcare Investors LLC